Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 22;15(10):e47486.
doi: 10.7759/cureus.47486. eCollection 2023 Oct.

Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside

K S Vidhya  1 , Ayesha Sultana  2 , Naveen Kumar M  3 , Harish Rangareddy  4
Affiliations
Review

Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside

K S Vidhya et al. Cureus. .

Abstract

Artificial intelligence (AI) techniques have the potential to revolutionize drug release modeling, optimize therapy for personalized medicine, and minimize side effects. By applying AI algorithms, researchers can predict drug release profiles, incorporate patient-specific factors, and optimize dosage regimens to achieve tailored and effective therapies. This AI-based approach has the potential to improve treatment outcomes, enhance patient satisfaction, and advance the field of pharmaceutical sciences. International collaborations and professional organizations play vital roles in establishing guidelines and best practices for data collection and sharing. Open data initiatives can enhance transparency and scientific progress, facilitating algorithm validation.

Keywords: artificial intelligence in healthcare; drug design; drug discovery research; future of healthcare; nano technology.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flowchart showing pharmaceutical drug manufacturing process
Figure 2
Figure 2. Flowchart showing areas of artificial intelligence application in drug design
Figure 3
Figure 3. Flowchart of overview of Virtual Screening
Figure 4
Figure 4. Schematic representation of Feedback System Control (FSC) in optimizing nanocarrier combination therapy
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
Figure 5
Figure 5. Stimulus responsive nanoplatforms in smart drug delivery system
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
Figure 6
Figure 6. Integrating wearable technologies with drug delivery systems
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
See this image and copyright information in PMC

References

    1. Artificial intelligence in healthcare: transforming the practice of medicine. Bajwa J, Munir U, Nori A, Williams B. Future Healthc J. 2021;8:188–194. - PMC - PubMed
    1. Imagenet: a large-scale hierarchical image database. Deng J, Dong W, Socher R, et al. 2009 IEEE Conf Comput Vis Pattern Recognit. 2009:248–255.
    1. Data-driven modeling methods and techniques for pharmaceutical processes. Dong Y, Yang T, Xing Y, et al. Processes. 2023;11:2096.
    1. Artificial intelligence in pharmaceutical and healthcare research. Bhattamisra SK, Banerjee P, Gupta P, et al. Big Data Cogn Comput. 2023;7:10.
    1. Machine learning directed drug formulation development. Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Adv Drug Deliv Rev. 2021;175:113806. - PubMed

LinkOut - more resources